Arrowstreet Capital’s iCAD Inc ICAD Stock Holding History

Arrowstreet Capital’s Portfolio ICAD Stock Details ICAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-36,337	Closed	-$320K	–	2400
2020 Q3	$320K	Buy	+36,337	New	+$359K	﹤0.01%	2128

Other funds holding ICAD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital's ICAD Position: Q4 2020 in Review

Arrowstreet Capital sold out of iCAD Inc (ICAD) in Q4 2020, closing a stake of 36,337 shares — an estimated $320K sold.

Arrowstreet Capital first reported a position in ICAD in Q3 2020 and held it in 1 quarter. The position peaked at $320K in Q3 2020. 85 funds tracked by Wall St. Rank hold ICAD as of Q4 2020.

Arrowstreet Capital reported no remaining iCAD Inc position as of Q4 2020 after selling out during the quarter.
Arrowstreet Capital sold 36,337 iCAD Inc shares in Q4 2020, an estimated $320K.
Arrowstreet Capital first reported a position in iCAD Inc in Q3 2020 and held it in 1 quarter.
Arrowstreet Capital's iCAD Inc position peaked at $320K in Q3 2020.
85 funds tracked by Wall St. Rank held iCAD Inc as of Q4 2020.

Based on Arrowstreet Capital's 13F filing for Q4 2020, filed 12 Feb 2021.